Skip to main content

Table 3 Mean and (SD) of spatiotemporal gait parameters for all patients before (Pre 1 and Pre 2 and after (Post 1) fampridine

From: Fampridine and quality of life in individuals with multiple sclerosis

Spatiotemporal gait parameters All patients (n = 50)
Pre 1 Pre 2 Post 1
Velocity (m s−1) 1.05 (0.49) 1.08 (0.51) 1.2 (0.48)**
Cadence (steps min−1) 105.18 (28.74) 106.57 (28.98) 112.79 (24.9)**
Step length (m) 0.57 (0.17) 0.58 (0.18) 0.62 (0.16)**
Step time (s) 0.63 (0.25) 0.62 (0.22) 0.56 (0.16)**
Step width (m) 0.13 (0.05) 0.13 (0.05) 0.12 (0.04)*
Stance time (% GC) 66.03 (5.39) 65.83 (5.6) 64.13 (4.51) £
Double supp. time (% GC) 32.53 (10.84) 31.91 (11.27) 29.06 (8.23) £
  1. The italic values correspond statistical significant differences
  2. p < 0.05 Pre 1 and Pre 2 versus Post 1
  3. ** p 10−3 Pre 1 and Pre 2 versus Post 1
  4. £ p 10−4 Pre 1 and Pre 2 versus Post 1